Evidence map›Paper›PMID 39694500›Full record

Observational studyFukushima journal of medical science2025

Drug resistance of Pseudomonas aeruginosa based on the isolation sites and types of gastrointestinal diseases: An observational study.

Hironori Tsujimoto, Yuji Fujikura, Taka-Aki Hamamoto, Hiroyuki Horiguchi, Risa Takahata, Yusuke Ishibashi, Takao Sugihara, Keita Kouzu, Yujiro Itazaki, Sei-Ichiro Fujishima and 4 more

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Fukushima journal of medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hironori TsujimotoDepartment of Surgery, National Defense Medical College.
Yuji FujikuraDepartment of Medical Risk Management and Infection Control, National Defense Medical College Hospital, National Defense Medical College.
Taka-Aki HamamotoDepartment of Laboratory Medicine, National Defense Medical College Hospital.
Hiroyuki HoriguchiDepartment of Surgery, National Defense Medical College.
Risa TakahataDepartment of Medical Risk Management and Infection Control, National Defense Medical College Hospital, National Defense Medical College.
Yusuke IshibashiDepartment of Surgery, National Defense Medical College.
Takao SugiharaDepartment of Surgery, National Defense Medical College.
Keita KouzuDepartment of Surgery, National Defense Medical College.
Yujiro ItazakiDepartment of Surgery, National Defense Medical College.
Sei-Ichiro FujishimaDepartment of Surgery, National Defense Medical College.
Koichi OkamotoDepartment of Surgery, National Defense Medical College.
Yoshiki KajiwaraDepartment of Surgery, National Defense Medical College.
Susumu MatsukumaDepartment of Laboratory Medicine, National Defense Medical College Hospital.
Hideki UenoDepartment of Surgery, National Defense Medical College.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWe investigated the drug resistance status of Pseudomonas aeruginosa (P. aeruginosa) focusing on its isolation sites and types of diseases.　Materials and methods: A microbiological laboratory database was searched to identify all clinical cultures positive for P. aeruginosa.　Clinicopathologic features and susceptibility of P. aeruginosa to any antibiotics were evaluated in patients admitted to the division of upper (Upper-GI group) or lower gastrointestinal surgery (Lower-GI group).　In addition, we investigated the susceptibility of P. aeruginosa to any antibiotics based on the isolation site.　Results:P. aeruginosa was frequently detected in the sputum and urine of the Upper-GI and Lower-GI groups, respectively.　Among P. aeruginosa isolates from drain discharge, a significantly higher rate of resistance to imipenem, amikacin, and ciprofloxacin was observed; among P. aeruginosa isolates from wounds, a substantially higher proportion had resistance to imipenem and cefozopran in the Upper-GI group.　However, there was no difference between the two groups in the drug resistance of P. aeruginosa isolated from urine, sputum, blood, and ascites.　P. aeruginosa isolated from sputum showed more resistance to imipenem and ciprofloxacin than those isolated from other sites.　Conclusion: There were significant differences in the drug resistance of P. aeruginosa based on the isolation sites and types of diseases.　.

Indexed as

Drug Resistance, BacterialGastrointestinal DiseasesPseudomonas aeruginosaPseudomonas InfectionsAdultAgedAged, 80 and overAnti-Bacterial AgentsFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedAnti-Bacterial Agentsdrug resistancePseudomonas aeruginosathe isolation sites

Identifiers

PMID39694500
PMCPMC11799663

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.